Iranian Journal of Public Health 2017. 46(11):1598-1600.

Molecular Diagnostics with Laboratory Finding in Patients with Myeloproliferative Neoplasms


Molecular Diagnostics with Laboratory Finding in Patients with Myeloproliferative Neoplasms


No keywords##

Full Text:



Tefferi A, Vardiman JW (2008). Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia, 22(1):14-22.

Scott LM (2011). The JAK2 exon 12 mutations: a comprehensive review. Am J Hematol, 86(8):668-76.

Movafagh A, Maleki F, Fadaie S, et al (2007). Persistent unstable chromosomal aberration in lymphocytes of radiotherapy workers after 1st mitotic division in Tehran, Iran. Pak J Med Sci, 23(2):254-258.

Pardanani A, Lasho TL, Finke C, Hanson CA, Tefferi A (2007). Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera. Leukemia, 21(9):1960-3.

Pietra D, Li S, Brisci A, Passamonti F, Rumi E, Theocharides A, et al (2008). Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. Blood, 111(3):1686-9.

Huang Q, Li X, Chen W, Weiss LM (2007). Absence of JAK-2V617F point mutations in multiple myeloma. Leukemia, 21(4): 813-4.

Movafagh A, Mirfakhraei R, Mousavi-Jarrahi A et al (2011). Frequent incidence of double minute chromosomes in cancers, with special up-to-date reference to leukemia. Asian Pac J Cancer Prev, 12(12):3453-6.

Puigdecanet E, Espinet B, Lozano JJ, et al (2008). Gene expression profiling distin-guishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia. Leukemia, 22(7):1368-76.

Williams DM, Kim AH, Rogers O, Spivak JL, Moliterno AR (2007). Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis. Exp Hematol, 35(11):1641-6.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.